Oncofid-P-B: a novel treatment for BCG unresponsive carcinoma in situ (CIS) of the bladder: Results of a prospective European Multicentre study at 15 months from treatment start-Reference-Cited by-同舟云学术

Oncofid-P-B: a novel treatment for BCG unresponsive carcinoma in situ (CIS) of the bladder: Results of a prospective European Multicentre study at 15 months from treatment start

Published:2022-01 Issue:1 Volume:40 Page:11.e9-11.e15
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Hurle Rodolfo,Guazzoni Giorgio,Colombo Piergiuseppe,Santoro Armando,De Cobelli Ottavio,Trapani Ettore Di,Nohales Gloria,Carlos Llorente,Duran-Merino Ramon,Lazzeri Massimo

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference26 articles.

1. Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

2. Postoperative mortality and complications after radical cystectomy for bladder cancer in Quebec: A population-based analysis during the years 2000-2009;Zakaria;Can Urol Assoc J,2014

3. Quality of Life After Radical Cystectomy;Tyson;Urol Clin North Am,2018

4. Microtubules as a target for anticancer drug;Jordan;Nat Rev Cancer,2004

5. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation;Gelderblom;Eur J Cancer,2001

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Delivery Systems and Pharmacotherapeutic Approaches for the Treatment of Non–muscle-invasive Bladder Cancer;European Urology Oncology;2024-06

2. A paclitaxel-hyaluronan conjugate (ONCOFID-P-B™) in patients with BCG-unresponsive carcinoma in situ of the bladder: a dynamic assessment of the tumor microenvironment;Journal of Experimental & Clinical Cancer Research;2024-04-10

3. Treating BCG-Induced Cystitis with Combined Chondroitin and Hyaluronic Acid Instillations in Bladder Cancer;Journal of Clinical Medicine;2024-03-31

4. Reciprocal Relationship Between Cancer Stem Cells and Myeloid-Derived Suppressor Cells: Implications for Tumor Progression and Therapeutic Strategies;Future Oncology;2024-02

5. New Intravesical Agents for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer;Bladder Cancer;2023-09-25